Literature DB >> 27155108

Diagnosis and Treatment of Eosinophilic Esophagitis in Adults.

Robert T Kavitt1, Ikuo Hirano2, Michael F Vaezi3.   

Abstract

Eosinophilic esophagitis is a relatively recently discovered disease of increasing incidence and prevalence and is a common cause of dysphagia and food bolus impaction. The definition of eosinophilic esophagitis continues to evolve, most recently with the characterization of proton pump inhibitor-responsive esophageal eosinophilia. The number of high-quality prospective, controlled trials guiding therapeutic decisions in eosinophilic esophagitis has increased steadily over the past several years. Treatment options at present focus on dietary therapy, particularly implementation of a 6-food elimination diet, and medical therapy, primarily the use of swallowed, topical corticosteroids. Proton pump inhibitors play an important role in current management. Conservative esophageal dilation is effective at ameliorating dysphagia in symptomatic patients with esophageal strictures. We conducted an evidence-based review of the diagnosis and treatment options in adults with eosinophilic esophagitis. The understanding of eosinophilic esophagitis continues to be refined. Continued validation of appropriate endpoints, however, is essential to establish the efficacy of existing and novel therapeutic approaches.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EoE; Eosinophilic esophagitis

Mesh:

Substances:

Year:  2016        PMID: 27155108     DOI: 10.1016/j.amjmed.2016.04.024

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.

Authors:  James D Lewis; Lindsey Albenberg; Dale Lee; Mario Kratz; Klaus Gottlieb; Walter Reinisch
Journal:  Inflamm Bowel Dis       Date:  2017-02       Impact factor: 5.325

Review 2.  Dysphagia in the Elderly.

Authors:  Scott M Smukalla; Irina Dimitrova; Jeremy M Feintuch; Abraham Khan
Journal:  Curr Treat Options Gastroenterol       Date:  2017-09

Review 3.  Proton Pump Inhibitors in Gastroesophageal Reflux Disease: Friend or Foe.

Authors:  C Prakash Gyawali
Journal:  Curr Gastroenterol Rep       Date:  2017-09

4.  Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.

Authors:  Tetsuo Shoda; Ting Wen; Julie M Caldwell; Netali Ben-Baruch Morgenstern; Garrett A Osswald; Mark Rochman; Lydia E Mack; Jennifer M Felton; J Pablo Abonia; Nicoleta C Arva; Dan Atkins; Peter A Bonis; Kelley E Capocelli; Margaret H Collins; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; John Leung; Paul A Menard-Katcher; Vincent A Mukkada; Philip E Putnam; Amanda K Rudman Spergel; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Seema S Aceves; Glenn T Furuta; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2021-10-21       Impact factor: 22.682

Review 5.  Managing Esophageal Dysphagia in the Elderly.

Authors:  Felice Schnoll-Sussman; Philip O Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2016-09

6.  Eosinophilic cholangitis is a potentially underdiagnosed etiology in indeterminate biliary stricture.

Authors:  Dirk Walter; Sylvia Hartmann; Eva Herrmann; Jan Peveling-Oberhag; Wolf O Bechstein; Stefan Zeuzem; Martin-Leo Hansmann; Mireen Friedrich-Rust; Jörg G Albert
Journal:  World J Gastroenterol       Date:  2017-02-14       Impact factor: 5.742

Review 7.  Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.

Authors:  Carmelo Scarpignato; Luigi Gatta; Angelo Zullo; Corrado Blandizzi
Journal:  BMC Med       Date:  2016-11-09       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.